• Incyte President and Global Head of R&D Pablo J. Cagnoni sold 2,642 common shares at $112.71 on Oct. 15, 2026.
• He exercised employee stock options for 2,642 shares the same day, at exercise prices ranging from $61.18 to $71.93.
• Direct beneficial ownership totaled 183,200 common shares following the transactions, disclosed in a Form 4 dated Oct. 19, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001205703-26-000032), on October 19, 2026, and is solely responsible for the information contained therein.